Arch Therapeutics's total assets for Q were $1.82M, an increase of 16.47% from the previous quarter. ARTH total liabilities were $4.12M for the fiscal quarter, a -57.04% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.